Position in DSGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$370,910
+$44,693 QoQ
Shares Held
34,860
+0.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. DSGN ranks #177 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in DSGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $370,910 | 34,860 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $326,217 | 34,778 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $348,895 | 46,334 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $162,828 | 48,317 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $178,984 | 46,369 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $326,590 | 52,932 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $272,050 | 50,567 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $177,774 | 53,067 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $211,381 | 52,452 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $134,789 | 50,864 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $123,843 | 52,476 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $325,017 | 51,590 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $298,239 | 51,688 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $529,580 | 51,616 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $865,627 | 51,772 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $675,192 | 48,228 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $456,786 | 28,284 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $498,617 | 23,289 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $155,552 | 10,589 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||